Search Results - "Wallen, M C"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Impediments to effective treatment of the dually diagnosed patient by Wallen, M C, Weiner, H D

    Published in Journal of psychoactive drugs (01-04-1989)
    “…Mental health and chemical dependency clinicians have differing beliefs in regard to the etiology, diagnosis, and treatment of dually diagnosed patients. The…”
    Get more information
    Journal Article
  2. 2

    Highly active zinc-finger nucleases by extended modular assembly by Bhakta, Mital S, Henry, Isabelle M, Ousterout, David G, Das, Kumitaa Theva, Lockwood, Sarah H, Meckler, Joshua F, Wallen, Mark C, Zykovich, Artem, Yu, Yawei, Leo, Heather, Xu, Lifeng, Gersbach, Charles A, Segal, David J

    Published in Genome research (01-03-2013)
    “…Zinc-finger nucleases (ZFNs) are important tools for genome engineering. Despite intense interest by many academic groups, the lack of robust noncommercial…”
    Get full text
    Journal Article
  3. 3

    Utilization of 12-step theme groups in a short-term chemical dependence treatment unit by Wallen, M C, Weiner, H D, Mansi, A, Deal, D

    Published in Journal of psychoactive drugs (01-07-1987)
    “…At Eagleville Hospital, staff have found that utilizing the theme-group process facilitates patient acceptance of 12-Step programs within a relatively short…”
    Get more information
    Journal Article
  4. 4

    Culture and social class as intervening variables in relapse prevention with chemically dependent women by Weiner, H D, Wallen, M C, Zankowski, G L

    Published in Journal of psychoactive drugs (01-04-1990)
    “…Craving and relapse are complex, poorly understood phenomena. A distinctive and baffling characteristic of the disease of chemical dependency is the continuing…”
    Get more information
    Journal Article
  5. 5

    Combined Buprenorphine and Clonidine for Short-Term Opiate Detoxification: Patient Perspectives by Wallen, Mark C., Lorman, William J., Gosciniak, Joyce L.

    Published in Journal of addictive diseases (15-03-2006)
    “…The approval in 2003 for the use of buprenorphine in opiate addiction treatment has provided physicians with a new pharmacological tool to combat opiate…”
    Get full text
    Journal Article